Eli Lilly and Company
-
Eli Lilly introduces Ramiven breast cancer patients
Abemaciclib is a CDK4/6 inhibitor which has now been approved for HR+ HER2 – node positive high-risk early breast cancer…
Read More » -
Lilly to rollout of Tempo personalised diabetes management platform
The platform consists of three key components – the Tempo Smart Button; a compatible app, TempoSmart; and a prefilled insulin…
Read More » -
Vineet Gupta joins Eli Lilly as GM of India affiliate
Gupta will take over from Luca Visini Eli Lilly and Company (India) has appointed Vineet Gupta as the General Manager…
Read More » -
Cipla, Sun Pharma in licensing agreement with Lilly
To expand access to COVID-19 treatment in India Cipla and Sun Pharma have signed a royalty-free, non-exclusive voluntary licensing agreement…
Read More » -
Eli Lilly and Company partners with Bill & Melinda Gates Foundation
The agreement will facilitate access to future Lilly therapeutic antibodies under development for the prevention and treatment of COVID-19 to…
Read More »
